Skip to content
Dx

HCPCS Level II · Procedures and professional services (temporary)

G2070Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

Terminated 12/31/2024

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About G2070

G2070 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program).

It was added to HCPCS effective 01/01/2020, and its current record took effect 01/01/2025.

It was terminated on 12/31/2024 and can't be billed for later dates of service.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Med assist tx implant
Date added
01/01/2020
Action effective
01/01/2025
Termination date
12/31/2024
BETOS
M5D

Related G20xx codes

Common questions about G2070

Is HCPCS G2070 still valid?

No. G2070 was terminated on 12/31/2024.

Does Medicare cover G2070?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.